Antiphospholipid syndrome and lupus nephritis treated with rituximab
RITUXIMAB EN NEFRITIS LUPICA CON SINDROME ANTIFOSFOLIPIDO
G Fraga, I Jimenez, M Diaz, F Calero, Y Arce, JL Rodriguez, J Cubells
Leído
6565
Vecesse ha leído el artículo
2158
Total PDF
4407
Total HTML
Información del artículo
ISSN: 20132514Idioma original: Inglés
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2026 1 | 39 | 5 | 44 |
| 2025 12 | 101 | 4 | 105 |
| 2025 11 | 78 | 0 | 78 |
| 2025 10 | 35 | 0 | 35 |
| 2025 9 | 31 | 0 | 31 |
| 2025 8 | 26 | 0 | 26 |
| 2025 7 | 39 | 0 | 39 |
| 2025 6 | 24 | 0 | 24 |
| 2025 5 | 59 | 0 | 59 |
| 2025 4 | 34 | 0 | 34 |
| 2025 3 | 64 | 0 | 64 |
| 2025 2 | 71 | 0 | 71 |
| 2025 1 | 48 | 0 | 48 |
| 2024 12 | 43 | 0 | 43 |
| 2024 11 | 44 | 0 | 44 |
| 2024 10 | 50 | 0 | 50 |
| 2024 9 | 52 | 0 | 52 |
| 2024 8 | 48 | 0 | 48 |
| 2024 7 | 30 | 0 | 30 |
| 2024 6 | 49 | 0 | 49 |
| 2024 5 | 48 | 0 | 48 |
| 2024 4 | 40 | 0 | 40 |
| 2024 3 | 29 | 2 | 31 |
| 2024 2 | 39 | 9 | 48 |
| 2024 1 | 25 | 9 | 34 |
| 2023 12 | 16 | 7 | 23 |
| 2023 11 | 40 | 7 | 47 |
| 2023 10 | 21 | 10 | 31 |
| 2023 9 | 26 | 10 | 36 |
| 2023 8 | 28 | 4 | 32 |
| 2023 7 | 28 | 7 | 35 |
| 2023 6 | 28 | 7 | 35 |
| 2023 5 | 43 | 11 | 54 |
| 2023 4 | 12 | 7 | 19 |
| 2023 3 | 30 | 12 | 42 |
| 2023 2 | 19 | 5 | 24 |
| 2022 1 | 29 | 11 | 40 |
| 2022 12 | 33 | 15 | 48 |
| 2022 11 | 28 | 13 | 41 |
| 2022 10 | 32 | 1208 | 1240 |
| 2022 9 | 36 | 16 | 52 |
| 2022 8 | 36 | 20 | 56 |
| 2022 7 | 24 | 14 | 38 |
| 2022 6 | 28 | 18 | 46 |
| 2022 5 | 22 | 12 | 34 |
| 2022 4 | 28 | 17 | 45 |
| 2022 3 | 37 | 21 | 58 |
| 2022 2 | 27 | 11 | 38 |
| 2021 1 | 28 | 18 | 46 |
| 2021 12 | 31 | 10 | 41 |
| 2021 11 | 24 | 15 | 39 |
| 2021 10 | 26 | 15 | 41 |
| 2021 9 | 18 | 11 | 29 |
| 2021 8 | 24 | 13 | 37 |
| 2021 7 | 36 | 17 | 53 |
| 2021 6 | 26 | 10 | 36 |
| 2021 5 | 16 | 8 | 24 |
| 2021 4 | 62 | 33 | 95 |
| 2021 3 | 27 | 16 | 43 |
| 2021 2 | 22 | 11 | 33 |
| 2020 1 | 32 | 15 | 47 |
| 2020 12 | 17 | 12 | 29 |
| 2020 11 | 21 | 12 | 33 |
| 2020 10 | 20 | 20 | 40 |
| 2020 9 | 10 | 8 | 18 |
| 2020 8 | 29 | 13 | 42 |
| 2020 7 | 22 | 9 | 31 |
| 2020 6 | 19 | 10 | 29 |
| 2020 5 | 21 | 4 | 25 |
| 2020 4 | 22 | 11 | 33 |
| 2020 3 | 21 | 6 | 27 |
| 2020 2 | 22 | 10 | 32 |
| 2020 1 | 28 | 7 | 35 |
| 2019 12 | 23 | 8 | 31 |
| 2019 11 | 20 | 11 | 31 |
| 2019 10 | 5 | 2 | 7 |
| 2019 9 | 15 | 7 | 22 |
| 2019 8 | 10 | 10 | 20 |
| 2019 7 | 18 | 11 | 29 |
| 2019 6 | 10 | 2 | 12 |
| 2019 5 | 8 | 4 | 12 |
| 2019 4 | 40 | 18 | 58 |
| 2019 3 | 11 | 7 | 18 |
| 2019 2 | 18 | 8 | 26 |
| 2019 1 | 24 | 8 | 32 |
| 2018 12 | 28 | 11 | 39 |
| 2018 11 | 28 | 10 | 38 |
| 2018 10 | 35 | 17 | 52 |
| 2018 9 | 22 | 13 | 35 |
| 2018 8 | 12 | 9 | 21 |
| 2018 7 | 12 | 8 | 20 |
| 2018 6 | 7 | 7 | 14 |
| 2018 5 | 13 | 14 | 27 |
| 2018 4 | 16 | 4 | 20 |
| 2018 3 | 10 | 9 | 19 |
| 2018 2 | 15 | 8 | 23 |
| 2018 1 | 12 | 6 | 18 |
| 2017 12 | 25 | 9 | 34 |
| 2017 11 | 19 | 6 | 25 |
| 2017 10 | 12 | 11 | 23 |
| 2017 9 | 17 | 8 | 25 |
| 2017 8 | 20 | 5 | 25 |
| 2017 7 | 20 | 11 | 31 |
| 2017 6 | 20 | 9 | 29 |
| 2017 5 | 14 | 4 | 18 |
| 2017 4 | 27 | 8 | 35 |
| 2017 3 | 10 | 1 | 11 |
| 2017 2 | 17 | 4 | 21 |
| 2016 1 | 15 | 3 | 18 |
| 2016 12 | 40 | 7 | 47 |
| 2016 11 | 40 | 34 | 74 |
| 2016 10 | 59 | 14 | 73 |
| 2016 9 | 51 | 6 | 57 |
| 2016 8 | 99 | 0 | 99 |
| 2016 7 | 93 | 0 | 93 |
| 2016 6 | 79 | 0 | 79 |
| 2016 5 | 112 | 0 | 112 |
| 2016 4 | 73 | 0 | 73 |
| 2016 3 | 62 | 0 | 62 |
| 2016 2 | 67 | 0 | 67 |
| 2015 1 | 84 | 0 | 84 |
| 2015 12 | 95 | 0 | 95 |
| 2015 11 | 68 | 0 | 68 |
| 2015 10 | 58 | 0 | 58 |
| 2015 9 | 42 | 0 | 42 |
| 2015 8 | 60 | 0 | 60 |
| 2015 7 | 52 | 0 | 52 |
| 2015 6 | 46 | 0 | 46 |
| 2015 5 | 68 | 0 | 68 |
| 2015 4 | 10 | 0 | 10 |
Mostrar todo
